Tamarack Advisers’s NEVRO CORP. NVRO Stock Holding History

Tamarack Advisers’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-40,000	Closed	-$4.72M	–	39
2019 Q4	$4.72M	Sell	40,000 -12,864	-24%	-$1.27M	1.08%	24
2019 Q3	$4.54M	Buy	52,864 +2,864	+6%	+$217K	1.18%	22
2019 Q2	$3.15M	Sell	50,000 -110,000	-69%	-$6.85M	0.96%	19
2019 Q1	$10M	Buy	+160,000	New	+$7.52M	3.97%	11
2017 Q2	–	Sell	-17,100	Closed	-$1.6M	–	38
2017 Q1	$1.6M	Buy	+17,100	New	+$1.55M	1%	25
2016 Q3	–	Sell	-82,200	Closed	-$6.06M	–	43
2016 Q2	$6.06M	Buy	+82,200	New	+$5.58M	2.33%	16

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Tamarack Advisers's NVRO Position: Q1 2020 in Review

Tamarack Advisers sold out of NEVRO CORP. (NVRO) in Q1 2020, closing a stake of 40,000 shares — an estimated $4.72M sold.

Tamarack Advisers first reported a position in NVRO in Q2 2016 and held it in 6 quarters. The position peaked at $10M in Q1 2019. 182 funds tracked by Wall St. Rank hold NVRO as of Q1 2020.

Tamarack Advisers reported no remaining NEVRO CORP. position as of Q1 2020 after selling out during the quarter.
Tamarack Advisers sold 40,000 NEVRO CORP. shares in Q1 2020, an estimated $4.72M.
Tamarack Advisers first reported a position in NEVRO CORP. in Q2 2016 and held it in 6 quarters.
Tamarack Advisers's NEVRO CORP. position peaked at $10M in Q1 2019.
182 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2020.

Based on Tamarack Advisers's 13F filing for Q1 2020, filed 14 May 2020.